Allergy and Immunology · Naples, FL
NPI
1841268133
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2500 Vanderbilt Beach Rd, Ste 1103
Naples, FL, 34109
Phone (239) 596-5560
Groups this clinician bills Medicare through
Medicare paid, 2024
$7.2M
134,700 services
Medicare patients, 2024
669
Average age 75
Drug cost, 2024
$1.7M
1,477 prescriptions
Company payments, 2025
$19K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin P Rosenbach was code J1556 (injection, immune globulin (bivigam), 500 mg), 74,060 times for 78 patients. In total Kevin P Rosenbach billed 134,700 services in 46 codes, and Medicare paid $7.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1556 Injection, immune globulin (bivigam), 500 mg | Office | 74,060 | 78 | $58.05 | $4.3M |
| J2357 Injection, omalizumab, 5 mg | Office | 14,431 | 30 | $29.84 | $431K |
| 95004 Test - Miscellaneous | Office | 5,381 | 75 | $3.11 | $17K |
| 95165 Treatment - Miscellaneous | Office | 4,925 | 140 | $12.09 | $60K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,710 | 43 | $0.09 | $423 |
| 95117 Treatment - Miscellaneous | Office | 2,153 | 197 | $8.98 | $19K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,536 | 13 | $0.07 | $114 |
| 95024 Test - Miscellaneous | Office | 1,432 | 52 | $6.87 | $9,842 |
| 96366 Intravenous Infusion, Hydration | Office | 1,331 | 86 | $16.81 | $22K |
| 96365 Intravenous Infusion, Hydration | Office | 1,021 | 86 | $51.79 | $53K |
| 96375 Injection Administration | Office | 920 | 49 | $12.73 | $12K |
| 99215 Office E&M - Established | Office | 515 | 336 | $146.10 | $75K |
| 95044 Test - Miscellaneous | Office | 514 | 14 | $4.08 | $2,095 |
| 99213 Office E&M - Established | Office | 347 | 251 | $68.23 | $24K |
| 96372 Injection Administration | Office | 264 | 59 | $11.08 | $2,924 |
By year: 2022 $2.8M for 65,562 services; 2023 $6.0M for 117,539 services; 2024 $7.2M for 134,700 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin P Rosenbach prescribed most often to Medicare patients was Oseltamivir Phosphate, with 192 prescriptions and refills. In total Kevin P Rosenbach wrote 1,477 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oseltamivir Phosphate Generic | 192 | 192 | 103 | $4,659 |
| Fluconazole Generic | 138 | 174 | 41 | $5,574 |
| Dexamethasone Sodium Phosphate Generic | 79 | 79 | 11 | $579 |
| Valacyclovir Valacyclovir Hcl | 54 | 83 | 28 | $3,517 |
| Diphenhydramine Hcl Generic | 51 | 52 | Under 11 | $372 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 49 | 49 | Under 11 | $544K |
| Epinephrine Generic | 49 | 49 | 46 | $13K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 45 | 45 | Under 11 | $423K |
| Sodium Chloride 0.9 % Sodium Chloride | 45 | 45 | Under 11 | $403 |
| Prednisone Generic | 40 | 54 | 23 | $548 |
| Montelukast Sodium Generic | 39 | 117 | 13 | $474 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 37 | 37 | 14 | $532 |
| Azithromycin Generic | 34 | 54 | 14 | $662 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 28 | 28 | Under 11 | $606 |
| Hydroxychloroquine Sulfate Generic | 22 | 42 | Under 11 | $953 |
Brand drugs: 353 claims; generic drugs: 1,124 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin P Rosenbach $19K ($19K in general payments such as food, travel and fees) from 22 companies. The largest payer was ADMA BioManufacturing LLC with $16K.
| Company | Payments | Amount |
|---|---|---|
| ADMA BioManufacturing LLC | 21 | $16K |
| Pharming Healthcare, Inc. | 7 | $453 |
| CSL Behring CSL.AX | 10 | $340 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $317 |
| Pfizer Inc. PFE | 12 | $231 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 9 | $192 |
| Amgen Inc. AMGN | 2 | $189 |
| Regeneron Pharmaceuticals, Inc. REGN | 1 | $121 |
| GC Biopharma USA, Inc. 006280.KS | 3 | $118 |
| Grifols Shared Services North America, Inc. | 1 | $97.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.